Journal article icon

Journal article

Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia.

Abstract:

Malaria causes illness or death in unprotected travelers. Primaquine prevents malaria by attacking liver-stage parasites, a property distinguishing it from most chemoprophylactics and obviating 4-week postexposure dosing. A daily adult regimen of 30 mg primaquine prevented malaria caused by Plasmodium falciparum and P. vivax for 20 weeks in 95 of 97 glucose-6-phosphate dehydrogenase (G6PD)-normal Javanese transmigrants in Papua, Indonesia. In comparison, 37 of 149 subjects taking placebo in a...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1086/324085

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Tropical Medicine
Role:
Author
Expand authors...
Journal:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume:
33
Issue:
12
Pages:
1990-1997
Publication date:
2001-12-05
DOI:
EISSN:
1537-6591
ISSN:
1058-4838
URN:
uuid:1409afd6-91af-4c45-bace-df6d534cad6f
Source identifiers:
81691
Local pid:
pubs:81691

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP